Publicaciones en las que colabora con Gorka San José Enériz (30)

2024

  1. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

    Hypertension, Vol. 81, Núm. 2, pp. 218-228

2023

  1. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

    Molecular Aspects of Medicine, Vol. 93

  2. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides

    JACC: Heart Failure, Vol. 11, Núm. 1, pp. 58-72

2020

  1. Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)

    Scientific Reports

  2. Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

    Nefrologia, Vol. 40, Núm. 3, pp. 223-236

  3. Reprint of “The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking”

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1867, Núm. 3

2019

  1. The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 9, pp. 1421-1432

  2. The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

    Cardiovascular Research, Vol. 115, Núm. 4, pp. 696-698

2018

  1. Myocardial remodeling in hypertension toward a new view of hypertensive heart disease

    Hypertension, Vol. 72, Núm. 3, pp. 549-558

2017

  1. Hypertensive Heart Disease

    Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526

  2. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

    Scientific Reports, Vol. 7

  3. MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure

    Scientific Reports, Vol. 7

  4. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

    Journal of Hypertension, Vol. 35, Núm. 4, pp. 853-861

  5. The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

    Medical Clinics of North America, Vol. 101, Núm. 1, pp. 43-52

2016

  1. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism

    Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138

  2. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure

    Journal of the American College of Cardiology, Vol. 67, Núm. 3, pp. 251-260

2015

  1. Circulating biomarkers of myocardial fibrosis: The need for a reappraisal

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2449-2456

2014

  1. microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation

    Clinical Science, Vol. 126, Núm. 7, pp. 497-506

2013

  1. A synthetic peptide from transforming growth factor-β1 Type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

    Antioxidants and Redox Signaling, Vol. 19, Núm. 14, pp. 1607-1618

  2. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

    Clinical Science, Vol. 125, Núm. 6, pp. 291-300